Semaglutide, marketed under brand names like Ozempic and Wegovy, belongs to a class of drugs known as GLP-1 receptor agonists. Semaglutide works by mimicking the action of a naturally occurring gut hormone called GLP-1.
GLP-1 is released after eating and plays a crucial role in regulating blood sugar levels and appetite. By acting like GLP-1, semaglutide stimulates insulin release while suppressing the release of glucagon, a hormone that raises blood sugar levels. Additionally, by slowing gastric emptying and promoting feelings of fullness, semaglutide assists in appetite control, making it a dual-purpose medication for diabetes management and weight management.